Implementing Shared Decision Making (SDM) for Individualized CV Prevention (SDM4IP)
实施共享决策 (SDM) 以实现个体化心血管预防 (SDM4IP)
基本信息
- 批准号:10611866
- 负责人:
- 金额:$ 65.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-05-01 至 2024-12-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdoptionAdultAmericanAmerican Heart AssociationAttitudeCardiologyCardiovascular DiseasesCardiovascular systemCaringClinic VisitsCluster randomized trialConsolidated Framework for Implementation ResearchDecision MakingDisease ManagementEffectivenessElectronicsEmotionalEvaluationEventEvidence based interventionExerciseFaceFosteringGoalsGuidelinesHealth systemHumanHybridsIndividualInterdisciplinary StudyInterventionLifeLife StyleLightMedicalMedicineMethodsMorbidity - disease rateMyocardial InfarctionOrganizational PolicyOutcomePatient-Centered CarePatientsPersonsPharmaceutical PreparationsPopulations at RiskPractice GuidelinesPreventionPreventivePreventive treatmentPrimary CarePrimary PreventionProcessPublic PolicyQuality of lifeRandomizedReach, Effectiveness, Adoption, Implementation, and MaintenanceRecommendationRegimenReportingResourcesRiskRisk ReductionStrokeTarget PopulationsTimeTranslatingWorkanalogblindcardiovascular risk factorclinical encounterclinical practicecollegecostdesigneffectiveness evaluationeffectiveness/implementation hybridevidence baseexperienceglucagon-like peptide 1high riskimplementation evaluationimplementation frameworkimplementation outcomesimplementation scienceimplementation strategyimplementation/effectivenessimprovedindividual patientinhibitorinnovationmortalitymultidisciplinarypharmacologicpreferencepreventpreventive interventionprimary care practiceprimary care settingpsychosocialrandomized trialresearch data disseminationroutine careroutine practiceshared decision makingsystemic barriertheoriestooltreatment as usualtreatment planningtreatment risktrenduptake
项目摘要
PROJECT SUMMARY/ABSTRACT
The primary prevention of cardiovascular (CV) events is often more intense in individuals at
lower risk and vice versa (risk-treatment paradox) in part due to unawareness of each person’s
CV risk, of their preferences for prevention interventions, and of their feasibility in each person’s
daily life. Extant practice guidelines recommend that clinicians and patients work together to
arrive at an effective and feasible prevention plan that is congruent with each person’s CV risk
and informed preferences, a process called shared decision making (SDM). An effective and
innovative tool that estimates CV risk and shows the impact and features of available lifestyle
and pharmacological preventive interventions for use during the clinical encounter to enable
SDM, the CV Prevention Choice tool, is available yet remains rarely used in practice.
Our broad goal is to promote patient-centered care that effectively reduces the substantial
burden of CV disease among Americans. This study, directly responsive to PA-19-166, seeks to
identify implementation approaches that foster routine SDM about primary CV prevention in a
diverse set of primary care practices across the U.S. This 5-year study – proposed by a
multidisciplinary team with expertise in preventive cardiology, SDM, and implementation science
– will draw on an implementation framework (Consolidated Framework for Implementation
Research), an implementation theory (Normalization Process Theory), and an evaluation
framework (RE-AIM) to design, conduct, and report a mixed method, hybrid implementation-
effectiveness (Type III), stepped-wedge clustered randomized trial to determine:
- Implementation effectiveness (Aim 1) by evaluating practice contexts and engagement of
users in implementation strategies, implementation outcomes (e.g., reach, adoption) associated
with these strategies, and how implementation fosters routine adoption of SDM and the CV
Prevention Choice tool in primary care practices, and
- SDM effectiveness (Aim 2) estimated by the extent to which individual CV prevention plans
are feasible and congruent with each person’s estimated CV risk and preferences.
By the project’s end, we expect to have (a) identified the most effective implementation
strategies to embed SDM in routine practice and (b) estimated the effectiveness of SDM to
achieve feasible and risk-concordant CV prevention in primary care.
项目总结/摘要
心血管(CV)事件的一级预防通常在以下个体中更为强烈:
风险较低,反之亦然(风险-治疗悖论),部分原因是没有意识到每个人的
心血管风险,他们对预防干预措施的偏好,以及他们在每个人的
日常生活现有的实践指南建议临床医生和患者共同努力,
制定一个有效可行的预防计划,与每个人的CV风险相一致
和知情的偏好,这一过程称为共享决策(SDM)。有效和
一种创新工具,可估计心血管风险并显示现有生活方式的影响和特征
和药理学预防性干预,用于临床治疗,
SDM是CV预防选择工具,但在实践中很少使用。
我们的广泛目标是促进以病人为中心的护理,有效地减少大量的
美国人的CV疾病负担。本研究直接响应PA-19-166,旨在
确定实施方法,促进常规SDM关于一级CV预防,
这项为期5年的研究-由一个
多学科团队,拥有预防心脏病学、SDM和实施科学方面的专业知识
- 将利用一个执行框架(综合执行框架
研究)、实施理论(规范化过程理论)和评估
框架(RE-AIM)设计、执行和报告混合方法、混合实施-
有效性(III型),阶梯楔形分组随机试验,以确定:
- 通过评价实践背景和参与情况,提高执行效力(目标1)
实施战略、实施成果中的用户(例如,达到,采用)相关
这些战略,以及实施如何促进常规采用SDM和CV
初级保健实践中的预防选择工具,以及
- SDM有效性(目标2)通过个人CV预防计划的程度进行评估
是可行的,符合每个人的估计CV风险和偏好。
到项目结束时,我们预计将:(a)确定最有效的实施办法,
将可持续发展机制纳入日常实践的战略,以及(B)估计可持续发展机制的有效性,
在初级保健中实现可行且风险一致的CV预防。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The design and development of an encounter tool to support shared decision making about preventing cardiovascular events.
- DOI:10.1016/j.pmedr.2022.101994
- 发表时间:2022-12
- 期刊:
- 影响因子:2.8
- 作者:Hartasanchez, Sandra A.;Hargraves, Ian G.;Clark, Jennifer E.;Gravholt, Derek;Brito, Juan P.;Branda, Megan E.;Gomez, Yvonne L.;Nautiyal, Vivek;Khurana, Charanjit S.;Thomas, Randal J.;Montori, Victor M.;Ridgeway, Jennifer L.
- 通讯作者:Ridgeway, Jennifer L.
Increasing risk-concordant cardiovascular care in diverse health systems: a mixed methods pragmatic stepped wedge cluster randomized implementation trial of shared decision making (SDM4IP).
- DOI:10.1186/s43058-021-00145-6
- 发表时间:2021-04-21
- 期刊:
- 影响因子:0
- 作者:Ridgeway JL;Branda ME;Gravholt D;Brito JP;Hargraves IG;Hartasanchez SA;Leppin AL;Gomez YL;Mann DM;Nautiyal V;Thomas RJ;Behnken EM;Torres Roldan VD;Shah ND;Khurana CS;Montori VM
- 通讯作者:Montori VM
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
VICTOR MANUEL MONTORI其他文献
VICTOR MANUEL MONTORI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('VICTOR MANUEL MONTORI', 18)}}的其他基金
Implementing Shared Decision Making (SDM) for Individualized CV Prevention (SDM4IP)
实施共享决策 (SDM) 以实现个体化心血管预防 (SDM4IP)
- 批准号:
10392952 - 财政年份:2020
- 资助金额:
$ 65.21万 - 项目类别:
Shared decision making for stroke prevention in atrial fibrillation (SDM4Afib)
心房颤动中风预防的共同决策 (SDM4Afib)
- 批准号:
9246591 - 财政年份:2016
- 资助金额:
$ 65.21万 - 项目类别:
Shared decision making for stroke prevention in atrial fibrillation (SDM4Afib)
心房颤动中风预防的共同决策 (SDM4Afib)
- 批准号:
9898425 - 财政年份:2016
- 资助金额:
$ 65.21万 - 项目类别:
Shared decision making for stroke prevention in atrial fibrillation (SDM4Afib)
心房颤动中风预防的共同决策 (SDM4Afib)
- 批准号:
9261196 - 财政年份:2016
- 资助金额:
$ 65.21万 - 项目类别:
Shared decision making for stroke prevention in atrial fibrillation (SDM4Afib)
心房颤动中风预防的共同决策 (SDM4Afib)
- 批准号:
9076319 - 财政年份:2016
- 资助金额:
$ 65.21万 - 项目类别:
Patient centered dissemination of evidence-based medicine - SHARE EBM
以患者为中心的循证医学传播 - SHARE EBM
- 批准号:
8793180 - 财政年份:2013
- 资助金额:
$ 65.21万 - 项目类别:
Patient centered dissemination of evidence-based medicine - SHARE EBM
以患者为中心的循证医学传播 - SHARE EBM
- 批准号:
8471311 - 财政年份:2013
- 资助金额:
$ 65.21万 - 项目类别:
Patient centered dissemination of evidence-based medicine - SHARE EBM
以患者为中心的循证医学传播 - SHARE EBM
- 批准号:
8643209 - 财政年份:2013
- 资助金额:
$ 65.21万 - 项目类别:
Translation of comparative effectiveness of depression medications into practice
将抑郁症药物的比较有效性转化为实践
- 批准号:
8007031 - 财政年份:2010
- 资助金额:
$ 65.21万 - 项目类别:
The Impact of Decision Aids to Enhance Shared Decision Making for Diabetes
决策辅助对增强糖尿病共同决策的影响
- 批准号:
7699932 - 财政年份:2009
- 资助金额:
$ 65.21万 - 项目类别:
相似海外基金
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
- 批准号:
10093543 - 财政年份:2024
- 资助金额:
$ 65.21万 - 项目类别:
Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
- 批准号:
24K16436 - 财政年份:2024
- 资助金额:
$ 65.21万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 65.21万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 65.21万 - 项目类别:
EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
- 批准号:
24K20973 - 财政年份:2024
- 资助金额:
$ 65.21万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 65.21万 - 项目类别:
EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
- 批准号:
10075502 - 财政年份:2023
- 资助金额:
$ 65.21万 - 项目类别:
Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
- 批准号:
10089082 - 财政年份:2023
- 资助金额:
$ 65.21万 - 项目类别:
EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 65.21万 - 项目类别:
Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
- 批准号:
2321091 - 财政年份:2023
- 资助金额:
$ 65.21万 - 项目类别:
Standard Grant